224 related articles for article (PubMed ID: 27424910)
1. Theranostic Imaging of Cancer Gene Therapy.
Sekar TV; Paulmurugan R
Methods Mol Biol; 2016; 1461():241-54. PubMed ID: 27424910
[TBL] [Abstract][Full Text] [Related]
2. Dual-therapeutic reporter genes fusion for enhanced cancer gene therapy and imaging.
Sekar TV; Foygel K; Willmann JK; Paulmurugan R
Gene Ther; 2013 May; 20(5):529-37. PubMed ID: 22914496
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive theranostic imaging of HSV1-sr39TK-NTR/GCV-CB1954 dual-prodrug therapy in metastatic lung lesions of MDA-MB-231 triple negative breast cancer in mice.
Sekar TV; Foygel K; Ilovich O; Paulmurugan R
Theranostics; 2014; 4(5):460-74. PubMed ID: 24669276
[TBL] [Abstract][Full Text] [Related]
4. Advances in imaging gene-directed enzyme prodrug therapy.
Bhaumik S
Curr Pharm Biotechnol; 2011 Apr; 12(4):497-507. PubMed ID: 21342105
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive optical imaging of nitroreductase gene-directed enzyme prodrug therapy system in living animals.
Bhaumik S; Sekar TV; Depuy J; Klimash J; Paulmurugan R
Gene Ther; 2012 Mar; 19(3):295-302. PubMed ID: 21753794
[TBL] [Abstract][Full Text] [Related]
6. SP94-Targeted Triblock Copolymer Nanoparticle Delivers Thymidine Kinase-p53-Nitroreductase Triple Therapeutic Gene and Restores Anticancer Function against Hepatocellular Carcinoma in Vivo.
Sukumar UK; Rajendran JCB; Gambhir SS; Massoud TF; Paulmurugan R
ACS Appl Mater Interfaces; 2020 Mar; 12(10):11307-11319. PubMed ID: 32048820
[TBL] [Abstract][Full Text] [Related]
7. Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects.
Ray P; Tsien R; Gambhir SS
Cancer Res; 2007 Apr; 67(7):3085-93. PubMed ID: 17409415
[TBL] [Abstract][Full Text] [Related]
8. Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET.
Tseng JC; Zanzonico PB; Levin B; Finn R; Larson SM; Meruelo D
J Nucl Med; 2006 Jul; 47(7):1136-43. PubMed ID: 16818948
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivo.
Harvey TJ; Hennig IM; Shnyder SD; Cooper PA; Ingram N; Hall GD; Selby PJ; Chester JD
Cancer Gene Ther; 2011 Nov; 18(11):773-84. PubMed ID: 21836632
[TBL] [Abstract][Full Text] [Related]
10. The piggyBac transposon is an integrating non-viral gene transfer vector that enhances the efficiency of GDEPT.
Kang Y; Zhang XY; Jiang W; Wu CQ; Chen CM; Gu JR; Zheng YF; Xu CJ
Cell Biol Int; 2009 Apr; 33(4):509-15. PubMed ID: 19353779
[TBL] [Abstract][Full Text] [Related]
11. Application of bioluminescence imaging to therapeutic intervention of herpes simplex virus type I - Thymidine kinase/ganciclovir in glioma.
Jang SJ; Kang JH; Kim KI; Lee TS; Lee YJ; Lee KC; Woo KS; Chung WS; Kwon HC; Ryu CJ; Choi TH; Choi CW; Lim SM; Cheon GJ
Cancer Lett; 2010 Nov; 297(1):84-90. PubMed ID: 20819721
[TBL] [Abstract][Full Text] [Related]
12. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
[TBL] [Abstract][Full Text] [Related]
13. Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application.
Fillat C; Carrió M; Cascante A; Sangro B
Curr Gene Ther; 2003 Feb; 3(1):13-26. PubMed ID: 12553532
[TBL] [Abstract][Full Text] [Related]
14. VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion construct.
Hakkarainen T; Wahlfors T; Meriläinen O; Loimas S; Hemminki A; Wahlfors J
J Gene Med; 2005 Jul; 7(7):898-907. PubMed ID: 15759279
[TBL] [Abstract][Full Text] [Related]
15. Genetically engineered theranostic mesenchymal stem cells for the evaluation of the anticancer efficacy of enzyme/prodrug systems.
Nouri FS; Wang X; Hatefi A
J Control Release; 2015 Feb; 200():179-87. PubMed ID: 25575867
[TBL] [Abstract][Full Text] [Related]
16. Bystander or no bystander for gene directed enzyme prodrug therapy.
Dachs GU; Hunt MA; Syddall S; Singleton DC; Patterson AV
Molecules; 2009 Nov; 14(11):4517-45. PubMed ID: 19924084
[TBL] [Abstract][Full Text] [Related]
17. Intravenous Administration Is an Effective and Safe Route for Cancer Gene Therapy Using the Bifidobacterium-Mediated Recombinant HSV-1 Thymidine Kinase and Ganciclovir.
Zhou H; He Z; Wang C; Xie T; Liu L; Liu C; Song F; Ma Y
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27275821
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound-guided delivery of thymidine kinase-nitroreductase dual therapeutic genes by PEGylated-PLGA/PIE nanoparticles for enhanced triple negative breast cancer therapy.
Devulapally R; Lee T; Barghava-Shah A; Sekar TV; Foygel K; Bachawal SV; Willmann JK; Paulmurugan R
Nanomedicine (Lond); 2018 May; 13(9):1051-1066. PubMed ID: 29790803
[TBL] [Abstract][Full Text] [Related]
19. Molecular Imaging of Tumor Angiogenesis and Therapeutic Effects with Dual Bioluminescence.
Wang R; Zhang K; Tao H; Du W; Wang D; Huang Z; Zhou M; Xu Y; Wang Y; Liu N; Wang H; Li Z
Curr Pharm Biotechnol; 2017; 18(5):422-428. PubMed ID: 28545358
[TBL] [Abstract][Full Text] [Related]
20. Prodrugs in genetic chemoradiotherapy.
Patterson AV; Saunders MP; Greco O
Curr Pharm Des; 2003; 9(26):2131-54. PubMed ID: 14529410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]